| Autor: |
Laurin O; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Baculea S; Global Market Access and Health Policy, Janssen Global Services LLC, High Wycombe, UK., Côté S; Global Market Access and Health Policy, Janssen Global Services LLC, Toronto, Canada., Spigelman S; Global Medical Affairs, Janssen Research and Development LLC, Raritan, NJ, USA., Szulkin R; SDS Life Science, Stockholm, Sweden., Kwok KH; Schain Research AB, Stockholm, Sweden., Schain F; Schain Research AB, Stockholm, Sweden., Jones CV; Schain Research AB, Stockholm, Sweden., Aly M; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden. markus.aly@ki.se. |
